SIRT1 and breast cancer: For instance, amurensin G suppresses SIRT1 and later inhibits MDR1 and FoxO1 levels within the doxorubicin-resistant BC cells, thus potentiating doxorubicin absorption into cells and suppressing oncogenic development (Oh et al., 2010).